Clinical trial
Combination Chemotherapy in Treating Patients With Breast Cancer
NCT00003088
Study timeline
Study start (unknown)1997-09-01Date precision: month
Registry last updated2020-04-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
paclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
OmahaNebraska, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1New OrleansLouisiana, United States1ScottsdaleArizona, United States1ToledoOhio, United States1PeoriaIllinois, United States1FargoNorth Dakota, United States1Sioux FallsSouth Dakota, United States1Des MoinesIowa, United States1UrbanaIllinois, United States1DuluthMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003088 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.